Edition:
United States

Aethlon Medical Inc (AEMD.OQ)

AEMD.OQ on NASDAQ Stock Exchange Capital Market

1.44USD
21 Feb 2018
Change (% chg)

-- (--)
Prev Close
$1.44
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
78,493
52-wk High
$5.17
52-wk Low
$0.80

Latest Key Developments (Source: Significant Developments)

Aethlon Medical Announces Fiscal 2018 Third Quarter Results
Thursday, 1 Feb 2018 04:15pm EST 

Feb 1 (Reuters) - Aethlon Medical Inc ::AETHLON MEDICAL ANNOUNCES FISCAL 2018 THIRD QUARTER RESULTS.Q3 LOSS PER SHARE $0.08.  Full Article

Aethlon Medical announces second quarter results
Thursday, 2 Nov 2017 04:15pm EDT 

Nov 2 (Reuters) - Aethlon Medical Inc :Aethlon Medical announces fiscal 2018 second quarter results.Q2 loss per share $0.14.  Full Article

AETHLON MEDICAL ANNOUNCES PRODUCTION COLLABORATION WITH IBIO INC
Monday, 16 Oct 2017 07:15am EDT 

Oct 16 (Reuters) - Aethlon Medical Inc ::AETHLON MEDICAL ANNOUNCES LARGE-SCALE PRODUCTION COLLABORATION.AETHLON MEDICAL INC - HAS ESTABLISHED A COLLABORATION WITH IBIO INC. TO SUPPORT POTENTIAL LARGE-SCALE PRODUCTION OF AETHLON HEMOPURIFIER​.  Full Article

IBIO ANNOUNCES MANUFACTURING COLLABORATION WITH AETHLON MEDICAL
Monday, 16 Oct 2017 07:15am EDT 

Oct 16 (Reuters) - iBio Inc ::IBIO ANNOUNCES MANUFACTURING COLLABORATION WITH AETHLON MEDICAL.IBIO INC - ‍AGREEMENT WITH AETHLON MEDICAL INC TO SUPPORT POTENTIAL LARGE-SCALE PRODUCTION OF AETHLON HEMOPURIFIER BLOOD PURIFICATION DEVICE​.  Full Article

Intracoastal Capital reports 5.7 pct passive stake in Aethlon Medical
Wednesday, 11 Oct 2017 06:09pm EDT 

Oct 11 (Reuters) - Aethlon Medical Inc :Intracoastal Capital LLC reports 5.7 percent passive stake in Aethlon Medical Inc as of Oct 2 - SEC filing‍​.  Full Article

Aethlon Medical received formal receipt from FDA for expedited access pathway program submission ‍​
Monday, 14 Aug 2017 03:38pm EDT 

Aug 14 (Reuters) - Aethlon Medical Inc ::On Aug 14, co received formal receipt from the U.S. FDA for expedited access pathway program submission ‍​.Submission formally requests that the Aethlon Hemopurifier be included in the FDA EAP program - SEC filing‍​.  Full Article

Aethlon Medical reports Q1 loss per share $0.21
Thursday, 10 Aug 2017 04:15pm EDT 

Aug 10 (Reuters) - Aethlon Medical Inc -:Aethlon Medical announces fiscal 2018 first quarter results.Q1 loss per share $0.21.Aethlon Medical - ‍finalized expedited access pathway program submission that its regulatory advisors will provide to united states FDA.Aethlon Medical Inc - ‍finalized submission requests that aethlon hemopurifier be included in eap program​.  Full Article

Aethlon Medical Inc files for stock offering of up to $13.3 mln - SEC filing
Monday, 31 Jul 2017 04:46pm EDT 

July 31 (Reuters) - Aethlon Medical Inc :Aethlon Medical Inc files for common stock offering of up to $13.3 million - SEC filing.  Full Article

Aethlon Medical ‍announces grant of U.S. patent
Wednesday, 19 Jul 2017 07:11am EDT 

July 19 (Reuters) - Aethlon Medical Inc -:Aethlon Medical Inc - ‍announces grant of a U.S. Patent protecting methods of capturing MHC antigen associated exosomes​.  Full Article

Aethlon Medical plans to submit expedited access pathway program submission to FDA
Wednesday, 28 Jun 2017 04:15pm EDT 

June 28 (Reuters) - Aethlon Medical Inc ::Aethlon Medical announces fiscal 2017 results.Aethlon Medical Inc - now plans to submit an expedited access pathway program submission to FDA.Aethlon Medical - if EAP submission is accepted by FDA, company believes regulatory advancement of hemopurifier could be accelerated in united states.  Full Article